Rv2686c-Rv2687c-Rv2688c, an ABC Fluoroquinolone Efflux Pump in Mycobacterium tuberculosis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2004-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.48.8.3175-3178.2004PMID 15273144PMCID PMC478549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of drug resistance in Mycobacterium tuberculosis.

  2009cited by this paper
• Molecular Cloning and Characterization of an ABC Multidrug Efflux Pump, VcaM, in Non-O1 Vibrio cholerae

  2003cited by this paper
• EfrAB, an ABC Multidrug Efflux Pump in Enterococcus faecalis

  2003cited by this paper
• The structure and function of drug pumps: an update.

  2003influential reference
• Prediction of Drug Resistance in M. tuberculosis: Molecular Mechanisms, Tools, and Applications

  2002cited by this paper
• Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis.

  2002cited by this paper
• CmeABC Functions as a Multidrug Efflux System in Campylobacter jejuni

  2002cited by this paper
• The Multidrug Transporters Belonging to Major Facilitator Superfamily (MFS) in Mycobacterium tuberculosis

  2002cited by this paper
• Characterization of P55, a Multidrug Efflux Pump inMycobacterium bovis and Mycobacterium tuberculosis

  2001cited by this paper
• The role of ABC transporters in antibiotic-producing organisms: drug secretion and resistance mechanisms.

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Efflux in bacteria: what do we really know about it?

  2001cited by this paper
• Evidence that phosphate specific transporter is amplified in a fluoroquinolone resistant Mycobacterium smegmatis.

  2000cited by this paper
• The ATP binding cassette (ABC) transport systems of Mycobacterium tuberculosis.

  2000cited by this paper
• Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance.

  2000cited by this paper
• Reversal of multidrug resistance of tumor cells.

  2000cited by this paper
• An ABC-type multidrug transporter of Lactococcus lactis possesses an exceptionally broad substrate specificity.

  2000cited by this paper
• mmr, a Mycobacterium tuberculosis Gene Conferring Resistance to Small Cationic Dyes and Inhibitors

  1998cited by this paper
• Molecular Cloning and Characterization of Tap, a Putative Multidrug Efflux Pump Present in Mycobacterium fortuitum and Mycobacterium tuberculosis

  1998cited by this paper
• Molecular Cloning and Functional Analysis of a Novel Tetracycline Resistance Determinant, tet(V), fromMycobacterium smegmatis

  1998cited by this paper
• Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis.

  1996cited by this paper
• Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump

  1996cited by this paper
• Mechanisms of drug resistance in Mycobacterium tuberculosis.

  1994cited by this paper

• Combating Multi-drug Resistant Mycobacterium Species by Efflux Pump Inhibitors: Contemporary Trends

  2025cites this paper
• Unveiling the response of efflux pump genes to delamanid in Mycobacterium tuberculosis H37Rv: a transcriptomic analysis.

  2025cites this paper
• Split-luciferin Assay for Real-time Measurement of Cytosolic Molecular Accumulation in Live Mycobacteria

  2025cites this paper
• Integrated transcriptomic and metabolomic analyses reveal the antibacterial mechanism of isocorydine against Mycobacterium bovis

  2025cites this paper
• Beyond Hotspot Mutations: Diagnostic Relevance of High Frequency, Low Frequency, and Disputed rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis

  2025cites this paper
• Whole Genome Sequencing and Metabolomic Profiling of Six Clinical Mycobacterium Tuberculosis Isolates Reveal Drug Resistance-Associated Features

  2025cites this paper
• Mycobacterium smegmatis MfpC is a GEF that regulates mfpA translationally to alter the fluoroquinolone efficacy

  2024cites this paper
• Emerging and alternative strategies for the treatment of nontuberculous mycobacterial infections

  2024cites this paper
• Exploring the transcription start sites and other genomic features facilitates the accurate identification and annotation of small RNAs across multiple stress conditions in Mycobacterium tuberculosis

  2024cites this paper
• Impact of MSMEG5257 Deletion on Mycolicibacterium smegmatis Growth

  2024cites this paper
• QMAC-DST for Rapid Detection of Drug Resistance in Pulmonary Tuberculosis Patients: A Multicenter Pre–Post Comparative Study

  2024cites this paper
• Efflux pump gene single nucleotide variants associated with resistance in Mycobacterium tuberculosis isolates with discrepant drug genotypes.

  2024cites this paper
• Targeting mycobacterial efflux system to enhance tuberculosis therapy

  2024cites this paper
• KNOWN MECHANISMS OF M. TUBERCULOSIS DRUG RESISTANCE TO MAJOR FIRST AND SECOND LINE ANTIMYCOBACTERIAL DRUGS

  2023cites this paper
• Understanding the Phage–Host Interaction Mechanism toward Improving the Efficacy of Current Antibiotics in Mycobacterium abscessus

  2023cites this paper
• Optimizing the use of current antituberculosis drugs to overcome drug resistance in Mycobacterium tuberculosis.

  2023cites this paper
• ABC superfamily transporter Rv1273c of Mycobacterium tuberculosis acts as a multidrug efflux pump.

  2023cites this paper
• Efflux pump effects on Mycobacterium tuberculosis drug resistance

  2023cites this paper
• Whole genome sequencing and global metabolome profiling of clinical Mycobacterium tuberculosis isolates provide insights to their drug resistance status.

  2022cites this paper
• The Iron Response of Mycobacterium tuberculosis and Its Implications for Tuberculosis Pathogenesis and Novel Therapeutics

  2022cites this paper
• Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review.

  2022cites this paper
• Unraveling the mechanisms of intrinsic drug resistance in Mycobacterium tuberculosis

  2022cites this paper
• Mycobacterium Fluoroquinolone Resistance Protein D (MfpD), a GTPase-Activating Protein of GTPase MfpB, Is Involved in Fluoroquinolones Potency

  2022cites this paper
• Critical discussion on drug efflux in Mycobacterium tuberculosis

  2021cites this paper
• Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance.

  2021cites this paper
• Prospects and Obstacles for Clinical Use of the Inhibitors of Mycobacterium tuberculosis Efflux Pumps

  2021influential citation
• Insight into using a novel ultraviolet/peracetic acid combination disinfection process to simultaneously remove antibiotics and antibiotic resistance genes in wastewater: Mechanism and comparison with conventional processes.

  2021cites this paper
• The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis

  2021cites this paper
• Impact of spent engine oil contamination on the antibiotic resistome of a tropical agricultural soil

  2021cites this paper
• The ATP-Binding Cassette (ABC) Transport Systems in Mycobacterium tuberculosis: Structure, Function, and Possible Targets for Therapeutics

  2020influential citation
• Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran

  2020cites this paper
• Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs

  2020influential citation
• Genotype analysis of ofloxacin-resistant multidrug-resistant Mycobacterium tuberculosis isolates in a multicentered study from India

  2020cites this paper
• Mycobacterium

  2020cites this paper
• Exploration of Ion Channels in Mycobacterium tuberculosis: Implication on Drug Discovery and Potent Drug Targets Against Tuberculosis

  2020cites this paper
• Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species

  2020cites this paper
• Drugs against Mycobacterium tuberculosis

  2020cites this paper
• Mycobacterium tuberculosis Rv1473 is a novel macrolides ABC Efflux Pump regulated by WhiB7.

  2019cites this paper
• Reduced Permeability to Rifampicin by Capsular Thickening as a Mechanism of Antibiotic Persistence in Mycobacterium tuberculosis

  2019cites this paper
• Verapamil as an Efflux Inhibitor Against Drug Resistant Mycobacterium Tuberculosis: A Review

  2019cites this paper
• Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells

  2019cites this paper
• Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates.

  2019cites this paper
• Efflux pump as alternate mechanism for drug resistance in Mycobacterium tuberculosis.

  2019cites this paper
• Mycobacterium smegmatis moxifloxacin persister cells produce high levels of hydroxyl radical, generating genetic resisters selectable not only with moxifloxacin, but also with ethambutol and isoniazid.

  2019cites this paper
• Insights on Mycobacterium leprae Efflux Pumps and Their Implications in Drug Resistance and Virulence

  2018cites this paper
• The challenge of drug resistant tuberculosis

  2018cites this paper
• Verapamil Targets Membrane Energetics in Mycobacterium tuberculosis

  2018cites this paper
• Identification of small molecular inhibitors for efflux protein Rv2688c of Mycobacterium tuberculosis

  2018cites this paper
• Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco

  2018cites this paper
• The Role of Efflux Pumps in Tuberculosis Treatment and Their Promise as a Target in Drug Development: Unraveling the Black Box.

  2018cites this paper
• Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis

  2018cites this paper
• The Mycobacterial Membrane: A Novel Target Space for Anti-tubercular Drugs

  2018cites this paper
• Molecular Analysis of Linezolid-Resistant Clinical Isolates of Mycobacterium abscessus

  2018cites this paper
• Single nucleotide polymorphisms in efflux pumps genes in extensively drug resistant Mycobacterium tuberculosis isolates from Pakistan.

  2017cites this paper
• Mycobacterium tuberculosis Major Facilitator Superfamily Transporters

  2017cites this paper
• Implications of Chromosomal Mutations for Mycobacterial Drug Resistance

  2017cites this paper
• Antimicrobial Drug Resistance

  2017cites this paper
• Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis

  2017cites this paper
• RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.

  2017cites this paper
• The Capacity of Mycobacterium tuberculosis To Survive Iron Starvation Might Enable It To Persist in Iron-Deprived Microenvironments of Human Granulomas

  2017cites this paper
• Mechanisms of Drug Action, Drug Resistance and Drug Tolerance in Mycobacterium tuberculosis: Expected Phenotypes from Evolutionary Pressures from a Highly Successful Pathogen

  2017cites this paper
• Antituberculosis drugs: reducing efflux=increasing activity.

  2017cites this paper
• Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors

  2017cites this paper
• New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria

  2017cites this paper
• Development of efflux pump inhibitors in antituberculosis therapy.

  2016cites this paper
• Antimicrobial Drug Efflux Pump Inhibitors

  2016cites this paper
• Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy

  2016cites this paper
• Human Tuberculosis II. M. tuberculosis Mechanisms of Genetic and Phenotypic Resistance to Anti-Tuberculosis Drugs.

  2016cites this paper
• REMap: Operon Map of M. tuberculosis

  2016cites this paper
• Efflux Pump Mediated Second-Line Tuberculosis Drug Resistance

  2016cites this paper
• Efflux Pumps in Mycobacteria: Antimicrobial Resistance, Physiological Functions, and Role in Pathogenicity

  2016cites this paper
• A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis.

  2016cites this paper
• REMap: Operon map of M. tuberculosis based on RNA sequence data.

  2016cites this paper
• EFFECT OF EFFLUX PUMP INHIBITORS ON RESISTANCE OF OFLOXACIN IN CLINICAL ISOLATES OF MYCOBACTERIUM TUBERCULOSIS

  2015cites this paper
• Eagle Effect in Nonreplicating Persister Mycobacteria

  2015cites this paper
• Genome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug Resistance

  2015cites this paper
• Nanocarrier-based interventions for the management of MDR/XDR-TB

  2015cites this paper
• Gene expression analysis of two extensively drug-resistant tuberculosis isolates show that two-component response systems enhance drug resistance.

  2015cites this paper
• Proteasome Accessory Factor C (pafC) Is a novel gene Involved in Mycobacterium Intrinsic Resistance to broad-spectrum antibiotics - Fluoroquinolones

  2015cites this paper
• Drug resistance to Mycobacterium tuberculosis: From the traditional Chinese view to modern systems biology

  2015cites this paper
• Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates

  2015cites this paper
• Adaptation of Mycobacterium to hospital disinfectants

  2015cites this paper
• Novel epitopes identified from efflux pumps of Mycobacterium tuberculosis could induce cytotoxic T lymphocyte response

  2015cites this paper
• Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy.

  2015cites this paper
• Eliminating the Heart from the Curcumin Molecule: Monocarbonyl Curcumin Mimics (MACs)

  2014cites this paper
• Mechanism in Mycobacterium tuberculosis Study of the Rifampin Monoresistance

  2014cites this paper
• Molecular Basis of Drug Resistance in Mycobacterium tuberculosis

  2014cites this paper
• Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.

  2014cites this paper
• Ofloxacin Resistance in Mycobacterium tuberculosis Is Associated with Efflux Pump Activity Independent of Resistance Pattern and Genotype

  2014cites this paper
• Mechanisms of fluoroquinolone monoresistance in Mycobacterium tuberculosis.

  2014cites this paper
• Energy Metabolism and Drug Efflux in Mycobacterium tuberculosis

  2014cites this paper
• Evaluation of the MTT and MABA assays for rapid screening of the in vitro activity of synthetic chalcones against Mycobacterium tuberculosis.

  2014cites this paper
• Reduced Emergence of Isoniazid Resistance with Concurrent Use of Thioridazine against Acute Murine Tuberculosis

  2014cites this paper
• IDENTIFYING GENETIC FACTORS PROMOTING FITNESS AND RIFAMPICIN TOLERANCE IN MYCOBACTERIUM TUBERCULOSIS BIOFILMS

  2014cites this paper
• The Molecular Genetics of Fluoroquinolone Resistance in Mycobacterium tuberculosis

  2014cites this paper
• Comparative genomic analysis of Mycobacterium tuberculosis clinical isolates

  2014cites this paper
• Efflux pumps in drug resistance of Mycobacterium tuberculosis: A panoramic view

  2014cites this paper
• Identification of novel leads applying in silico studies for Mycobacterium multidrug resistant (MMR) protein

  2014influential citation
• The Structural Modeling of the Interaction between Levofloxacin and the Mycobacterium tuberculosis Gyrase Catalytic Site Sheds Light on the Mechanisms of Fluoroquinolones Resistant Tuberculosis in Colombian Clinical Isolates

  2014cites this paper
• NON-TUBERCULOUS MYCOBACTERIA: GENERAL Characterisation of a putative AraC transcriptional regulator from Mycobacterium smegmatis

  2014cites this paper